On Track for Wellness: a stepped-wedge program to boost sleep and activity in first-episode psychosis
Official title: On Track for Wellness: Stepped-wedge Cluster Randomized Trial of a Fitbit Enhanced Health Intervention for Early Onset Psychosis
Run by University of Illinois Chicago · NCT07387705 · Data updated 2026-11-12
This program tests whether using Fitbit trackers, health education, and goal setting helps people with first-episode psychosis sleep better and move more.
Quick facts
| Study type | Interventional |
|---|---|
| Sex | All |
| Enrollment | 365 (estimated) |
| Sponsor | University of Illinois Chicago Academic / other |
| Locations | 1 site (Chicago, Illinois) |
| Status | Recruiting |
| Started | September 1, 2026 |
| Main results expected | September 1, 2030 |
| Study ends | December 1, 2030 |
| Registry record updated | October 27, 2026 |
| Trial ID | NCT07387705 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Programs that provide first-episode psychosis services funded by the Illinois Department of Human Services can participate, with enrollment at the program level.
✕Probably not a fit
Individuals in programs not adopting OTW or in settings outside Illinois DHS-funded early psychosis services may not experience benefits from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The trial tests the On Track for Wellness (OTW) program across Illinois’ early psychosis programs using a stepped-wedge cluster design. Phase 1 collects qualitative feedback from staff and clients in two programs, while phase 2 trains remaining programs and uses administrative data and Fitbit information to measure changes over three years. The study emphasizes real-world implementation within state-funded services and relies on program-level enrollment rather than individual enrollment. Outcomes focus on sleep hygiene and physical activity, informing whether OTW can be scaled within state systems. Lead oversight is by the University of Illinois Chicago, with Illinois DHS DBHR guiding deployment.
Why it matters
Potential benefit: If successful, OTW could improve sleep and activity levels for people with early psychosis, potentially supporting better overall health and functioning.
How similar studies have gone: Prior similar efforts using activity tracking and health education have shown promise in behavior change, though this specific stepped-wedge, program-level design is relatively novel in this setting.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Client at First Episode psychosis program funded by the Illinois Department of Human Services. Enrollment is at program level; no individual subject enrollment. \- Exclusion Criteria: not a client at a First Episode psychosis program funded by the Illinois Department of Human Services. Enrollment is at program level; no individual subject enrollment. \-
Where it's running
-
University of Illinois Chicago
Chicago, Illinois, United States Recruiting
Study contacts
- Principal investigator: Judith A Cook, Ph.D — University of Illinois Chicago
- Study coordinator: Judith A Cook, Ph.D.
- Email: jcook@uic.edu
- Phone: 312-355-3921
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Adding ketones to antipsychotics in young adults with first episode psychosis
This study tests whether giving exogenous ketones on top of antipsychotic treatment helps young adults experiencing a first episode of psychosis.
-
Add CBD to antipsychotic treatment for first-episode psychosis to see if it helps more than placebo
This study tests whether adding cannabidiol (CBD) to ongoing antipsychotic treatment helps people with a first episode of psychosis who haven’t fully responded to their first antipsychotic, compared with a placebo.
-
Digital strategies to improve help-seeking for youth at risk of psychosis
This study is testing new digital tools to help young people aged 12-29 who are at risk for psychosis find the support they need and start treatment faster.
-
Digital tools to help youth seek care sooner when at risk for psychosis
This project will test personalized digital messages and online strategies to help people ages 12–29 who screen positive for psychosis risk find and start local care sooner.
-
Biomarkers to predict mood-related versus other courses and treatment response after a first psychotic episode
This project will test whether recorded interviews, clinical scales, blood markers and brain imaging can help predict who will go on to develop mood-related psychosis (bipolar/depressive with psychotic features) versus other psychoses and who will respond to treatment over two years in people aged 15–30 after their fir
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.